Cargando…
Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries
BACKGROUND: In 2009, the Global Fund to Fight AIDS, Tuberculosis and Malaria established the Affordable Medicines Facility-malaria (AMFm) in order to increase access to quality-assured artemisinin combination therapy (QAACT). AMFm Phase 1, which includes nine pilot programmes in eight countries, was...
Autores principales: | Davis, Ben, Ladner, Joel, Sams, Kelley, Tekinturhan, Ebru, de Korte, Donald, Saba, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637826/ https://www.ncbi.nlm.nih.gov/pubmed/23607504 http://dx.doi.org/10.1186/1475-2875-12-135 |
Ejemplares similares
-
Changes in the availability and affordability of subsidised artemisinin combination therapy in the private drug retail sector in rural Ghana: before and after the introduction of the AMFm subsidy
por: Ansah, Evelyn K., et al.
Publicado: (2016) -
Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program
por: Tekinturhan, Ebru, et al.
Publicado: (2013) -
The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy
por: O’Meara, Wendy Prudhomme, et al.
Publicado: (2013) -
Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries
por: Ladner, Joël, et al.
Publicado: (2017) -
Subsidising artemisinin‐based combination therapy in the private retail sector
por: Opiyo, Newton, et al.
Publicado: (2016)